DE60316709D1 - Indole-3-carbonsaüreamide als glucokinase (gk) aktivatoren - Google Patents
Indole-3-carbonsaüreamide als glucokinase (gk) aktivatorenInfo
- Publication number
- DE60316709D1 DE60316709D1 DE60316709T DE60316709T DE60316709D1 DE 60316709 D1 DE60316709 D1 DE 60316709D1 DE 60316709 T DE60316709 T DE 60316709T DE 60316709 T DE60316709 T DE 60316709T DE 60316709 D1 DE60316709 D1 DE 60316709D1
- Authority
- DE
- Germany
- Prior art keywords
- gluccokinase
- carbonateaureamides
- activators
- indole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41573702P | 2002-10-03 | 2002-10-03 | |
US415737P | 2002-10-03 | ||
PCT/EP2003/010776 WO2004031179A1 (en) | 2002-10-03 | 2003-09-26 | Indole-3-carboxamides as glucokinase (gk) activators |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60316709D1 true DE60316709D1 (de) | 2007-11-15 |
DE60316709T2 DE60316709T2 (de) | 2008-07-17 |
Family
ID=32069904
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60316709T Expired - Lifetime DE60316709T2 (de) | 2002-10-03 | 2003-09-26 | Indole-3-carbonsaüreamide als glucokinase (gk) aktivatoren |
Country Status (29)
Country | Link |
---|---|
US (1) | US6881844B2 (de) |
EP (1) | EP1549638B1 (de) |
JP (1) | JP4390704B2 (de) |
KR (1) | KR100646486B1 (de) |
CN (1) | CN100348596C (de) |
AR (1) | AR041467A1 (de) |
AT (1) | ATE374768T1 (de) |
AU (1) | AU2003270285B2 (de) |
BR (1) | BR0315047A (de) |
CA (1) | CA2499329C (de) |
DE (1) | DE60316709T2 (de) |
DK (1) | DK1549638T3 (de) |
ES (1) | ES2293005T3 (de) |
HK (1) | HK1083098A1 (de) |
HR (1) | HRP20050287A2 (de) |
MX (1) | MXPA05003391A (de) |
MY (1) | MY136764A (de) |
NO (1) | NO20051103L (de) |
NZ (1) | NZ538466A (de) |
PA (1) | PA8584001A1 (de) |
PE (1) | PE20050090A1 (de) |
PL (1) | PL375149A1 (de) |
PT (1) | PT1549638E (de) |
RU (1) | RU2309956C2 (de) |
SI (1) | SI1549638T1 (de) |
TW (1) | TW200413364A (de) |
UY (1) | UY28005A1 (de) |
WO (1) | WO2004031179A1 (de) |
ZA (1) | ZA200502619B (de) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0102299D0 (sv) | 2001-06-26 | 2001-06-26 | Astrazeneca Ab | Compounds |
SE0102764D0 (sv) | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
CA2498089A1 (en) * | 2002-10-03 | 2004-06-17 | Novartis Ag | Substituted (thiazol-2-yl) -amide or sulfonamide as glycokinase activators useful in the treatment of type 2 diabetes |
GB0226931D0 (en) | 2002-11-19 | 2002-12-24 | Astrazeneca Ab | Chemical compounds |
GB0226930D0 (en) * | 2002-11-19 | 2002-12-24 | Astrazeneca Ab | Chemical compounds |
EP1532980A1 (de) * | 2003-11-24 | 2005-05-25 | Novo Nordisk A/S | N-Heteroaryl Indol-Carboxamide und deren analoga zur Vewendung als glucokinase Aktivatoren zur Behandlung von Diabetes |
PT1735322E (pt) | 2004-04-02 | 2012-01-12 | Novartis Ag | Derivados de sulfonamido-tiazolopiridina como activadores de glucoquinase úteis para o tratamento de diabetes de tipo 2 |
KR20070006816A (ko) | 2004-04-02 | 2007-01-11 | 노파르티스 아게 | 티아졸로피리딘 유도체, 이를 함유하는 제약 조성물 및글루코키나제 매개형 증상의 치료 방법 |
WO2006112549A1 (ja) | 2005-04-20 | 2006-10-26 | Takeda Pharmaceutical Company Limited | 縮合複素環化合物 |
US7622492B2 (en) | 2005-08-31 | 2009-11-24 | Hoffmann-La Roche Inc. | Pyrazolones as inhibitors of 11β-hydroxysteroid dehydrogenase |
JP2007063225A (ja) | 2005-09-01 | 2007-03-15 | Takeda Chem Ind Ltd | イミダゾピリジン化合物 |
CA2624102A1 (en) | 2005-09-29 | 2007-04-12 | Sanofi-Aventis | Phenyl- and pyridinyl- 1, 2 , 4 - oxadiazolone derivatives, processes for their preparation and their use as pharmaceuticals |
GT200600429A (es) * | 2005-09-30 | 2007-04-30 | Compuestos organicos | |
CA2623958C (en) * | 2005-09-30 | 2013-05-28 | Banyu Pharmaceutical Co., Ltd. | 2-heteroaryl-substituted indole derivative |
GT200600428A (es) * | 2005-09-30 | 2007-05-21 | Compuestos organicos | |
JP2009013065A (ja) * | 2005-10-14 | 2009-01-22 | Astellas Pharma Inc | 縮合へテロ環化合物 |
JP2009515997A (ja) * | 2005-11-18 | 2009-04-16 | タケダ サン ディエゴ インコーポレイテッド | グルコキナーゼ活性剤 |
US7351706B2 (en) * | 2006-01-05 | 2008-04-01 | Hoffmann-La Roche Inc. | Indol-3-yl-carbonyl-spiro-piperidine derivatives |
EP2001875A2 (de) | 2006-03-08 | 2008-12-17 | Takeda San Diego, Inc. | Glucokinase-aktivatoren |
EP1849785A1 (de) * | 2006-04-28 | 2007-10-31 | Neuropharma, S.A. | N-(2-Thiazolyl)-Amid-Derivative als GSK-3 Inhibitoren |
PE20110235A1 (es) | 2006-05-04 | 2011-04-14 | Boehringer Ingelheim Int | Combinaciones farmaceuticas que comprenden linagliptina y metmorfina |
JP5386350B2 (ja) | 2006-05-31 | 2014-01-15 | タケダ カリフォルニア インコーポレイテッド | グルコキナーゼ活性剤としての、インダゾールおよびイソインドール誘導体 |
MX2009003972A (es) | 2006-10-19 | 2009-04-27 | Takeda Pharmaceutical | Compuesto de indol. |
WO2008074694A1 (en) * | 2006-12-20 | 2008-06-26 | F. Hoffmann-La Roche Ag | Crystallization of glucokinase activators |
JP5419706B2 (ja) | 2006-12-20 | 2014-02-19 | タケダ カリフォルニア インコーポレイテッド | グルコキナーゼアクチベーター |
US8173645B2 (en) | 2007-03-21 | 2012-05-08 | Takeda San Diego, Inc. | Glucokinase activators |
EA020332B1 (ru) * | 2007-08-10 | 2014-10-30 | Х. Лундбекк А/С | Аналоги гетероариламидов |
UY31830A (es) | 2008-05-16 | 2010-01-05 | Takeda Pharmaceutical | Activadores de glucoquinasa |
WO2010107736A2 (en) * | 2009-03-20 | 2010-09-23 | University Of Virginia Patent Foundation | Broad spectrum benzothiophene-nitrothiazolide and other antimicrobials |
JP2011006366A (ja) | 2009-06-26 | 2011-01-13 | Sanwa Kagaku Kenkyusho Co Ltd | 新規チオフェンカルボキサミド誘導体及びその医薬用途 |
EP2632460B1 (de) | 2010-09-20 | 2018-02-28 | University of Virginia Patent Foundation | Thiophen-derivate zur verwendung in der behandlung von tuberkulose |
CN103044310B (zh) * | 2013-01-18 | 2015-02-04 | 贵阳医学院 | 二氢吲哚-3-乙酸衍生物、其制备方法以及在药物中的应用 |
EP4419503A1 (de) * | 2021-10-20 | 2024-08-28 | Council of Scientific and Industrial Research, an Indian Registered Body Incorporated under Regn. of Soc. Act (Act XXI of 1860) | Verfahren zur herstellung von indol-3-carbonsäure-derivaten |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2740686B1 (fr) | 1995-11-03 | 1998-01-16 | Sanofi Sa | Formulation pharmaceutique lyophilisee stable |
US6262096B1 (en) | 1997-11-12 | 2001-07-17 | Bristol-Myers Squibb Company | Aminothiazole inhibitors of cyclin dependent kinases |
US6040321A (en) | 1997-11-12 | 2000-03-21 | Bristol-Myers Squibb Company | Aminothiazole inhibitors of cyclin dependent kinases |
JP5278983B2 (ja) | 1999-11-17 | 2013-09-04 | 塩野義製薬株式会社 | アミド化合物の新規用途 |
AU2190202A (en) | 2000-12-06 | 2002-06-18 | Hoffmann La Roche | Fused heteroaromatic glucokinase activators |
US6433188B1 (en) | 2000-12-06 | 2002-08-13 | Wendy Lea Corbett | Fused heteroaromatic glucokinase activators |
US6482951B2 (en) | 2000-12-13 | 2002-11-19 | Hoffmann-La Roche Inc. | Isoindolin-1-one glucokinase activators |
TWI312779B (de) | 2000-12-28 | 2009-08-01 | Daiichi Seiyaku Co | |
UA77303C2 (en) * | 2002-06-14 | 2006-11-15 | Pfizer | Derivatives of thienopyridines substituted by benzocondensed heteroarylamide useful as therapeutic agents, pharmaceutical compositions and methods for their use |
-
2003
- 2003-09-26 CN CNB038236796A patent/CN100348596C/zh not_active Expired - Fee Related
- 2003-09-26 ES ES03750648T patent/ES2293005T3/es not_active Expired - Lifetime
- 2003-09-26 NZ NZ538466A patent/NZ538466A/en unknown
- 2003-09-26 KR KR1020057005669A patent/KR100646486B1/ko not_active IP Right Cessation
- 2003-09-26 PT PT03750648T patent/PT1549638E/pt unknown
- 2003-09-26 EP EP03750648A patent/EP1549638B1/de not_active Expired - Lifetime
- 2003-09-26 DK DK03750648T patent/DK1549638T3/da active
- 2003-09-26 BR BR0315047-0A patent/BR0315047A/pt not_active IP Right Cessation
- 2003-09-26 AT AT03750648T patent/ATE374768T1/de not_active IP Right Cessation
- 2003-09-26 RU RU2005113719/04A patent/RU2309956C2/ru not_active IP Right Cessation
- 2003-09-26 JP JP2004540731A patent/JP4390704B2/ja not_active Expired - Fee Related
- 2003-09-26 AU AU2003270285A patent/AU2003270285B2/en not_active Ceased
- 2003-09-26 PL PL03375149A patent/PL375149A1/xx not_active Application Discontinuation
- 2003-09-26 SI SI200331008T patent/SI1549638T1/sl unknown
- 2003-09-26 CA CA002499329A patent/CA2499329C/en not_active Expired - Fee Related
- 2003-09-26 MX MXPA05003391A patent/MXPA05003391A/es active IP Right Grant
- 2003-09-26 WO PCT/EP2003/010776 patent/WO2004031179A1/en active IP Right Grant
- 2003-09-26 DE DE60316709T patent/DE60316709T2/de not_active Expired - Lifetime
- 2003-09-30 US US10/674,481 patent/US6881844B2/en not_active Expired - Fee Related
- 2003-09-30 TW TW092127030A patent/TW200413364A/zh unknown
- 2003-09-30 PA PA20038584001A patent/PA8584001A1/es unknown
- 2003-09-30 PE PE2003000988A patent/PE20050090A1/es not_active Application Discontinuation
- 2003-10-01 MY MYPI20033742A patent/MY136764A/en unknown
- 2003-10-01 UY UY28005A patent/UY28005A1/es not_active Application Discontinuation
- 2003-10-01 AR ARP030103589A patent/AR041467A1/es unknown
-
2005
- 2005-03-01 NO NO20051103A patent/NO20051103L/no not_active Application Discontinuation
- 2005-03-24 HR HR20050287A patent/HRP20050287A2/xx not_active Application Discontinuation
-
2006
- 2006-01-19 ZA ZA200502619A patent/ZA200502619B/en unknown
- 2006-04-10 HK HK06104334A patent/HK1083098A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60316709D1 (de) | Indole-3-carbonsaüreamide als glucokinase (gk) aktivatoren | |
DK1572670T3 (da) | 5-substitueret-pyrazin eller -pyridin-glucokinaseaktivatorer | |
ATE297921T1 (de) | Tetrazolylphenyl-acetamide als glukokinaseaktivatoren | |
DE50304983D1 (de) | Heteroaryloxy-substituierte phenylaminopyrimidine als rho-kinaseinhibitoren | |
DE60330694D1 (de) | Pyrimidopyrimidone als kinaseinhibitoren | |
NO20043116L (no) | Amidderivater som GK-aktivatorer | |
DE60336538D1 (de) | Stabilisiervorrichtung | |
DE60305903D1 (de) | Tropanderivative als ccr5-modulatoren | |
NO20044046L (no) | Substituerte hydroksyetylaminer | |
DE60312863D1 (de) | Fahrgestell | |
ATE496887T1 (de) | Substituierte 5-aminomethyl-1h-pyrrol-2-carbons ureamide | |
DE602004004295D1 (de) | 6-ä(substituiertes)phenylütriazolopyrimidine als antikrebsmittel | |
DE60236403D1 (de) | Tourbillonmechanismus | |
NO20023047D0 (no) | Kompenseringsanordning | |
ITMI20020198A0 (it) | (per)aloeteri | |
DE60217480D1 (de) | 17-METHYLEN-ANDROSTAN-3a-OL-ANALOGA ALS CRH- INHIBITOREN | |
DE50310329D1 (de) | Steuergerat | |
DE60315020D1 (de) | (2s)-2-ethylphenylpropionsäurederivat | |
DE60309612D1 (de) | Steuergerät | |
DE50205540D1 (de) | Steuergerät | |
FI20021277A0 (fi) | Tuloilmalaite | |
DE60327250D1 (de) | Modifizierte bace | |
ATE350379T1 (de) | Substituierte benzdioxepine | |
SE0203213D0 (sv) | Resevåg | |
ITLE20020026A1 (it) | Compensatore di ossigeno |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |